SDZ - Sandoz Group AG - Stock Price & Dividends

Sandoz Group AG is a leading global player in the development, manufacturing, and marketing of high-quality generic pharmaceuticals and biosimilars, catering to diverse therapeutic areas worldwide.

The company's extensive portfolio covers a broad range of therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. This comprehensive approach enables Sandoz to provide affordable and accessible treatment options to patients across the globe.

In addition to its finished dosage forms, Sandoz also offers a robust portfolio of active pharmaceutical ingredients, which are essential components in the production of medicines. This dual approach allows the company to cater to the diverse needs of its customers and partners.

With a rich history dating back to 1886, Sandoz Group AG is headquartered in Basel, Switzerland, and has established itself as a trusted name in the global pharmaceutical industry. For more information, please visit their official website at https://www.sandoz.com.